Commentary · 29 Aug 2025
EditorialPublished 1 Oct 2020
Emerging advances of nanomedicine in cancer therapy.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer has become a major cause for deaths around the world, affecting over 10 million new patients every year. At present various treatment methods for cancer includes surgical resection, radiation, and chemotherapy. Although more than 90 chemotherapeutic drugs have been approved by the FDA for therapeutic use, their safety and efficacy has been severely reduced by dose-limiting toxicity and patient morbidity. The common materials used as nanocarriers in nanomedicines for cancer therapy includes polymers, biological nanomaterials, inorganic nanomaterials, liposomes, hydrogels, hybrid nanomaterials and micelles. Compared to conventional therapy, nanotherapeutic drug delivery systems have several potential advantages for cancer therapy, including higher payload capacity, prolonged blood circulation times, reduced toxicity to healthy tissues, and improved anti-tumor efficacy.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Molecular Oncology Research.
Opinion · 29 Aug 2025
Targeting DNA repair mechanisms: A frontier in molecular oncology research
Rapid communication · 29 Aug 2025
Unlocking the future of cancer care: The role of molecular biomarkers in molecular oncology research
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Oncology Research
- SubjectOncology & Cancer
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Orkideh Martias”
